| Patient | Diana Spencer |
|---|---|
| Date of birth | 1961-07-01 |
| Identifiers | MRN HR-ML028-SYN-TD; SSN (made up) 000-28-5197 |
| Document date | 1990-05-11 |
| Author | Imogen Castleford, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Three-month review: binge and purge frequency, electrolytes, dental care, mood, and safety. [S]
Ms. Spencer returns three months after her first visit. She has had sixteen CBT-E sessions and is now working with her therapist on her concerns about shape and weight and on binges that follow difficult days. She has had two episodes of binge eating with vomiting in the last four weeks, both after long working days. She eats three meals and two snacks on six or seven days a week. She saw a dentist three weeks ago: the erosion was confirmed, a fluoride varnish was applied, no new decay was found, and a review was set for six months. She takes fluoxetine 60 mg each morning and an over-the-counter folic acid tablet. She completed the mid-treatment EDE-Q with her therapist. Her mood is good and she has had no thoughts of suicide or self-harm. [S]
| Element | Detail |
|---|---|
| Binge eating and vomiting | Two episodes in the last four weeks |
| CBT-E | Sixteen sessions; weekly |
| Regular eating | Three meals and two snacks on six or seven days a week |
| Dental examination | Done three weeks ago; fluoride varnish; review in six months |
| Mood | Good; PHQ-9 5; item 9 scored 0 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good; weight steady |
| Gastrointestinal | Negative | Two episodes of vomiting in four weeks; no heartburn or abdominal pain |
| Ears, nose, mouth, and throat | Negative | Tooth sensitivity better since the varnish |
| Psychiatric | Negative | Mood good; no thoughts of suicide or self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Potassium chloride 20 mEq extended-release oral tablet, one tablet by mouth twice daily with food | One tablet by mouth twice daily with food, swallowed whole with a full glass of water | Oral route | 1990-02-09 to 1990-03-16 | completed | S |
| Fluoxetine 20 mg oral capsule, one capsule by mouth each morning for one week, then two capsules each morning for one week | One capsule each morning for one week, then two capsules each morning for one week | Oral route | 1990-02-16 to 1990-03-02 | completed | S |
| Fluoxetine 60 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1990-03-02 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1990-05-11 | Body height | 178 | cm | S |
| 1990-05-11 | Body weight | 62 | kg | S |
| 1990-05-11 | Body mass index (BMI) [Ratio] | 19.6 | kg/m2 | S |
| 1990-05-11 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1990-05-11 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1990-05-11 | Heart rate | 68 | /min | S |
| 1990-05-11 | Respiratory rate | 14 | /min | S |
| 1990-05-11 | Body temperature | 36.6 | Cel | S |
| 1990-05-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1990-05-11 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1990-05-11 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1990-05-11 | Chloride [Moles/volume] in Serum or Plasma | 102 | mmol/L | 98-107 mmol/L | Normal | S |
| 1990-05-11 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 1990-05-11 | Creatinine [Mass/volume] in Serum or Plasma | 0.79 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1990-05-11 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1985)/1.73 sq M | 104 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1990-05-11 | Amylase [Enzymatic activity/volume] in Serum or Plasma | 88 | U/L | 28-100 U/L | Normal | S |
| 1990-05-11 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S |
Vital signs recorded on 1990-05-11; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 62.0 kg, BMI 19.6; lying blood pressure 108/68 and pulse 68, standing 108/70 and pulse 76 after three minutes |
| Head and neck | Parotid glands now barely enlarged; enamel erosion stable |
| Skin | Knuckle calluses gone |
| Psychiatric | Euthymic and engaged; organized |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Bulimia nervosa, severe: recurrent binge eating, each time with self-induced vomiting, averaging about ten episodes a week for about three years, hidden from everyone; self-worth tied closely to body shape and weight; no laxatives, diuretics, diet pills, or excessive exercise. SCOFF 4 of 5; EDE-Q global score 3.9. Findings: bilateral parotid enlargement, enamel erosion on the inner surfaces of the upper front teeth, calluses on the backs of two knuckles of the right hand, a pulse rise of 22 per minute on standing, low potassium and chloride with a raised bicarbonate, and a raised amylase; BMI 19.3. Synthetic modern episode linked to her own public account of bulimia | active | confirmed | F50.23 | S — Synthetic modern diagnosis by DSM-5-TR criteria; severity is graded by the average number of compensatory episodes a week (8 to 13 is severe). |
| Hypokalemia (potassium 3.1 mmol/L) with low chloride and metabolic alkalosis from repeated vomiting; QTc 452 ms; no palpitations, weakness, or fainting | resolved | confirmed | E87.6 | S — Synthetic presenting laboratory finding; resolved when potassium was normal on two checks. |
| Major depressive disorder, recurrent, moderate: about two months of low mood, tiredness, poor sleep, and feeling worthless and hopeless, with little pleasure in things she used to enjoy; PHQ-9 14 with item 9 scored 0; an earlier episode of depression after childbirth. Synthetic modern episode linked to her own public account of depression | active | confirmed | F33.1 | S — Synthetic modern diagnosis; the earlier episode is the post-natal depression she described publicly. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Binge-eating and vomiting frequency (her self-monitoring record) | Every visit | Completed today | Two episodes in the last four weeks |
| Survey | Eating Disorder Examination Questionnaire (EDE-Q) global score | Baseline, mid-treatment, and end of treatment | Completed today | Global score 2.1 at mid-treatment, from 3.9 |
| Examination | Weight and BMI | Every visit, and weekly in CBT-E sessions | Completed today | 62.0 kg, BMI 19.6 |
| Examination | Lying and standing pulse and blood pressure | Every visit while purging continues | Completed today | Lying 108/68, pulse 68; standing 108/70, pulse 76 (rise 8) |
| Laboratory | Potassium, chloride, bicarbonate, and creatinine | Weekly until potassium is normal twice, then at each medical visit while purging continues | Completed today | Potassium 4.1 mmol/L off supplements; sodium 139, chloride 102, bicarbonate 25 mmol/L; creatinine 0.79 mg/dL, eGFR 104 |
| Laboratory | Amylase | Baseline with parotid enlargement; repeat as indicated | Completed today | 88 U/L, from 146 at intake |
| Laboratory | ECG with QTc | Baseline with purging or low potassium; after a QT-relevant medicine reaches its full dose while potassium has been low | Not indicated | QTc 441 ms on fluoxetine 60 mg with normal potassium; no further routine ECG unless symptoms, low potassium, or a new QT-relevant medicine |
| Examination | Parotid and dental examination; dental protection | Every visit; a dental examination soon after diagnosis and regular dental reviews while vomiting continues | Completed today | Dental examination done three weeks ago, about ten weeks after it was advised at intake; erosion stable, fluoride varnish, no new decay, review in six months. The delay is closed; no harm resulted |
| Medication safety | Fluoxetine dose, adherence, and side effects (nausea, sleep, agitation, sexual effects, suicidal thoughts) | At the start, one to two weeks after starting or a dose change, then every visit | Completed today | 60 mg; no side effects; no agitation or suicidal thoughts |
| Self-management | CBT-E attendance and progress | Up to 20 sessions over 20 weeks, twice weekly for the first four weeks | Completed today | Sixteen sessions; weekly |
| Self-management | Regular eating and dietitian review | Every visit | Completed today | Three meals and two snacks on six or seven days a week |
| Survey | Depression measure (PHQ-9) | Monthly during acute treatment, then periodically | Completed today | PHQ-9 5, item 9 scored 0 |
| Survey | Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan current |
Goal progress:
Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Eating disorders: recognition and treatment (NICE guideline NG69) (2017, updated 2020); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)
Follow-up: CBT-E weekly to session 20. End-of-treatment review in about nine weeks with electrolytes, the EDE-Q, and the PHQ-9. Next scheduled visit 1990-07-13: end-of-treatment review after 20 weeks of CBT-E: remission, relapse prevention, and continuing fluoxetine. [S]